Table 5.
Spearman rho correlation of Angiogenic and Oxidative biomarkers with antepartum and postpartum adverse pregnancy outcome in Gestational hypertensive women
| PLGF | sFlt-1 | 8-epi-PGF2α | T-AOC | |
|---|---|---|---|---|
| Antepartum complications | ||||
| IUGR | r = −0.109; | r = 0.027; | r = 0.009; | r = −0.203; |
| p = 0.060 | p = 0.901 | p = 0.725 | p = 0.197 | |
| Placental abruptio/praevia | r = −0.033; | r = 0.040; | r = 0.022; | r = −0.107; |
| p = 0.683 | p = 0.259 | p = 0.901 | p = 0.443 | |
| IUFD | r = −0.191; | r = 0.150; | r = 0.083; | r = −0.196; |
| p = 0.071 | p = 0.092 | p = 0.724 | p = 0.173 | |
| Postpartum adverse outcomes | ||||
| Stillbirth | r = −0.066; | r = 0.001; | r = 0.113; | r = −0.191; |
| p = 0.483 | p = 0.933 | p = 0.270 | p = 0.420 | |
| PPH | r = −0.057; | r = 0.019; | r = 0.181; | r = −0.159; |
| p = 0.183 | p = 0.396 | p = 0.317 | p = 0.158 | |
r: correlation coefficient; p < 0.05 (statistically significant) p < 0.001 (statistically highly significant) p < 0.0001 (statistically very highly significant). r < 0.5 (weak correlation); r > 0.5 (strong correlation)